Global options for rapid approval and access present significant opportunity in the US, Europe, and now Japan. Yet postapproval demands for value demonstration, along with the diversity of payer and regulatory requirements in these regions, have generated unanticipated challenges. PAREXEL will present unique solutions that leverage the benefits of development acceleration, strategically balanced with clinical evidence and real-world innovations that support reimbursement.
